Eikon Therapeutics, Inc. (EIKN) return on equity (ROE)
There is no return on equity history on record here for Eikon Therapeutics, Inc. (EIKN). Figures as of 18 Nov 2026, 04:22 UTC, from Yahoo Finance.
Figures as of . Statements from Yahoo Finance. Figures, not advice.
Not enough data
A history of return on equity needs at least 3 fiscal years; none is on record here for Eikon Therapeutics, Inc.. Nothing is estimated to fill the gap.
How it is calculated
Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.
How to read it
It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.
Eikon Therapeutics, Inc., figure by figure
- Eikon Therapeutics, Inc. market cap
- Eikon Therapeutics, Inc. revenue
- Eikon Therapeutics, Inc. earnings
- Eikon Therapeutics, Inc. earnings per share (EPS)
- Eikon Therapeutics, Inc. P/E ratio
- Eikon Therapeutics, Inc. P/S ratio
- Eikon Therapeutics, Inc. P/B ratio
- Eikon Therapeutics, Inc. free cash flow
- Eikon Therapeutics, Inc. operating margin
- Eikon Therapeutics, Inc. dividend
- Eikon Therapeutics, Inc. shares outstanding
- Eikon Therapeutics, Inc. total debt
- Eikon Therapeutics, Inc. cash on hand
- Eikon Therapeutics, Inc. total assets
- Eikon Therapeutics, Inc. return on invested capital (ROIC)
Eikon Therapeutics, Inc. (EIKN) overview: price, valuation and scorecard
Eikon Therapeutics, Inc. return on equity (ROE): questions and answers
How is Eikon Therapeutics, Inc.'s return on equity calculated?
Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.
Fiscal years are named for the calendar year they end in.
Learn: return on equity (ROE)
All stocks guides →- Return on invested capital (ROIC) vs ROE and ROA
Return on invested capital (ROIC) is after-tax operating profit divided by the money tied up in the business: debt plus equity, less cash. A company earning $15 million after tax on $100 million of invested capital has a 15% ROIC. Unlike return on equity, it does not rise just because a company borrows more.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Eikon Therapeutics, Inc. (EIKN) return on equity (ROE)”, data as of 18 November 2026. https://funkfolio.com/stock/EIKN/roe
Underlying data: Yahoo Finance.